Westfield, NJ, United States of America

Tanya MacNeil


Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1987-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Tanya MacNeil

Introduction

Tanya MacNeil is a notable inventor based in Westfield, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of avermectin compounds. With a total of 3 patents, her work has had a substantial impact on the pharmaceutical industry.

Latest Patents

One of her latest patents involves a strain of Streptomyces avermitilis capable of glycosylating avermectin. This innovative strain allows for the glycosylation of avermectin compounds at the 4', 13-, or 14a-positions by adding the compounds to the fermentation medium. The glycosylation occurs specifically with an oleandrose group, enhancing the efficacy of these compounds as potent anthelmintic and antiparasite agents. Another significant patent focuses on cloning genes from Streptomyces avermitilis for avermectin biosynthesis. This patent discloses plasmids containing DNA isolated from the microorganism, which is essential for the preparation of avermectin compounds. The methods for isolating and manipulating these plasmids are also detailed, providing a pathway for altering the formation of avermectin compounds.

Career Highlights

Tanya MacNeil is currently employed at Merck & Company, Inc., where she continues to advance her research in biotechnology. Her work has been instrumental in developing new methods and compounds that address various health challenges.

Collaborations

Some of her notable coworkers include Douglas J MacNeil and Keith M Gewain, who have collaborated with her on various projects within the company.

Conclusion

Tanya MacNeil's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…